On November 21, 2019, Centene Corporation announced the pricing of an offering of $7,000,000,000 aggregate principal amount of senior notes. The $7,000,000,000 of senior notes will include $1,000,000,000 aggregate principal amount of additional 4.750% senior notes due 2025 (the “Additional 2025 Notes”) at a premium to yield 3.76%, $2,500,000,000 aggregate principal amount of new 4.250% senior notes due 2027 (the “2027 Notes”) at a discount to yield 4.375% and $3,500,000,000 aggregate principal amount of new 4.625% senior notes due 2029 (the “2029 Notes” and, together with the Additional 2025 Notes and the 2027 Notes, the “Notes”), to be to be issued by the Company. The Company intends to use the net proceeds of the 2027 Notes and the 2029 Notes and a portion of the proceeds of the Additional 2025 Notes to finance the cash consideration payable in connection with the Company's previously announced acquisition of WellCare Health Plans Inc. (“WellCare”) and to pay related fees and expenses. The Company expects to use the remainder of the net proceeds of the Additional 2025 Notes for general corporate purposes, including the repayment of revolver borrowings. The Notes have not been registered under the Securities Act of 1933, as amended, and may not be offered or sold in the United States without registration or an applicable exemption from the registration requirements.